Impact of CYP2C19 Polymorphisms on Clinical Outcomes and Antiplatelet Potency of Clopidogrel in Caucasian Poststroke Survivors.
第一作者:
Aleš,Tomek
第一单位:
Department of Neurology, 2nd Faculty of Medicine, Charles University, Prague and Motol University Hospital, Prague, Czech Republic.;Molecular Genetics Laboratory, Hospital Na Homolce, Prague, Czech Republic.
作者:
主题词
年龄因素(Age Factors);老年人(Aged);女(雌)性(Female);基因型(Genotype);杂合子(Heterozygote);人类(Humans);脑缺血发作, 短暂性(Ischemic Attack, Transient);男(雄)性(Male);中年人(Middle Aged);心肌梗死(Myocardial Infarction);血小板聚集(Platelet Aggregation);血小板聚集抑制剂(Platelet Aggregation Inhibitors);多态现象, 遗传(Polymorphism, Genetic);回顾性研究(Retrospective Studies);危险性评估(Risk Assessment);卒中(Stroke);幸存患者(Survivors);噻氯匹定(Ticlopidine);治疗结果(Treatment Outcome)
DOI
10.1097/MJT.0000000000000416
PMID
29509167
发布时间
2022-12-07
- 浏览0
American journal of therapeutics
e202-e212页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文